insights_auto
Why is CUV down 2,84%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,52
arrow_downward
-2,84%(-0,22) 1D
6 ພ.ຈ., 16 ໂມງ 10 ນາທີ 28 ວິນາທີ GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$8,30
High
A$8,30
Low
A$7,39
Mkt. cap
379,66 ລ້ານ
Avg. vol.
157,70 ພັນ
Volume
172,46 ພັນ
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
3 ກ.ຍ. 2026
P/E ratio
11,26
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 ລ້ານ
No. of employees
16
Open
A$8,30
High
A$8,30
Low
A$7,39
Mkt. cap
379,66 ລ້ານ
Avg. vol.
157,70 ພັນ
Volume
172,46 ພັນ
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
3 ກ.ຍ. 2026
P/E ratio
11,26
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 ລ້ານ
No. of employees
16
News stories
From web sources and news partners
The Business Journal
·
10 ຊົ່ວໂມງກ່ອນ
AI stocks bounce back as S&P 500 trims weekly loss to 2.7%
Yahoo Finance
·
21 ຊົ່ວໂມງກ່ອນ
Dow Jones Industrial Average ETF (DIA) Buys $96.4 Million More Goldman on Nov. 4
Trefis
·
2 ຊົ່ວໂມງກ່ອນ
8 S&P 500 Stocks Just Made New 52-Week Highs
Barron's
·
19 ຊົ່ວໂມງກ່ອນ
S&P 500 Futures Rise in Premarket Trading; JFrog, Cloudflare Lead
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com